Page 2 - Recent Corporate Developments News Today

Closed private placement in April 2022, with net proceeds of approximately $6.9 millionSigned multiple strategic agreements and collaborations to further...

BRYAN, Texas, Feb. 14, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...

Capricor Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update May 13, 2021 16:05 ET | Source: Capricor Therapeutics Capricor Therapeutics -- -Data for Phase II INSPIRE Clinical Trial Expected in Third Quarter- -Plan to File IND for Multivalent Exosome-mRNA Vaccine for SARS-CoV-2 in Third Quarter- -To Host Conference Call and Webcast Today at 4:30 p.m. ET- -- LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDA...

Atlas Reports First Quarter 2021 Results News provided by Share this article Funds from Operations Growth of 27.6% in Q1 Adjusted EBITDA Growth of 21.1% in Q1 $12.1 Billion Atlas Corp. Revenue growth of 20.8% to $372.6 million for the quarter ended March 31, 2021 Funds From Operations ("FFO") (4) growth of 13.2% to $0.60 for the quarter ended March 31, 2021 Adjusted EBITDA (4) growth of 21.1% to $237.9 million for the quarter ended March 31, 2021 LONDON, May 3, 2021 /PRNewswire/ - Atlas Co...

Nuran Provides Update on Operations in Cameroon and DRC ACCESSWIRE 29 Apr 2021, 22:05 GMT+10 QUEBEC, QC / ACCESSWIRE / April 29, 2021 / NuRAN Wireless Inc. (NuRAN or the Company) (CSE:NUR)(OTC PINK:NRRWF)(FSE:1RN) is pleased to provide the following update on the progress of its Network as a Service (NAAS) contracts with Orange S.A. (ORAN) and its affiliates previously announced February 8, 2021 and March 11, 2021 for the build out of networking sites in Cameroon and Democratic Republic of the ...

Atlas Reports Fourth Quarter and Full Year 2020 Results News provided by Share this article (1) of gross contracted cash flows since November 2020 Revenue Growth of 25.9% in Q4 and 25.6% in FY2020 Funds from Operations Growth of 45.2% in Q4 and 65.8% in FY2020 Adjusted EBITDA Growth of 32.0% in Q4 and 29.3% in FY2020 Atlas Recognizes Asset Impairment driven by Legacy Technologies in APR Energy Atlas Corp.  Financial Performance: Revenue growth of 25.9% to $362.7 million and 25.6% to a reco...